There are 44 million people in the US who can use this device at home with their family or watching TV rather than taking time off work to visit a clinic.
La Jolla, CA (PRWEB) September 16, 2014
Skylit Medical announces the formation of the corporation under the Chairmanship of David F. Hale. The company is dedicated to providing personal, private, UV therapy for patients with psoriasis, eczema and vitiligo. Their devices will be used in patient homes but can connect wirelessly to a dermatologist, clinic, managed care organization or telehealth platform.
Mr. Hale was previously a CEO of Hybritech, and has since led several successful startups as Chairman. These companies include Santarus, Inc., which was acquired by Salix in 2014 for $2.6 billion, Micromet, which was acquired by Amgen for $1.16 billion and Skinmedica, which was acquired by Allergan in 2012 for $350 million.
Skylit was founded by Martyn Gross, a psoriasis patient, and is headquartered at EvoNexus, a Commnexus Incubator, in La Jolla, California. Previously, the company graduated from StartR Accelerator at UCSD and is a member of the inaugural class of Founder.org.
The Executive Team represents extensive experience in the medical field. As CFO, Kathy Scott’s credentials include completing billions of dollars in acquisitions, mergers, and restructurings with RA Capital Advisors. Remo Moomiaie, Ph.D., is Skylit's Chief Innovation Officer and co-founder, and has invented several medical devices after being trained as a surgeon at Yale School of Medicine. Andre Gamelin, Vice President of Research and Development, formerly at Masimo Corporation and Carefusion, has 24 years of experience engineering innovative electro-mechanical and electro-optical products, primarily in the medical device field.
Skylit Medical’s vision includes providing access to clinical phototherapy for any patient who needs it. The company is developing an innovative UVB phototherapy device and service that includes safety and control mechanisms like no other treatment for psoriasis, vitiligo and eczema patients.
Mr. Gross founded the company as a patient with mild psoriasis who was disappointed with the treatments offered to him. “The most effective therapy for me involved taking 4-5 hours out of my week to visit a phototherapy clinic for about one minute of treatment,” Mr. Gross stated. “My Health Savings Account was drained after a couple months, and I was stuck with topical steroids that didn’t work or biologics that, for me, were too extreme. That’s why I created Skylit Medical. There are 44 million people in the US who can use this device at home with their family or watching TV rather than taking time off work to visit a clinic.”
An integral component of the new device will be its ability to sync wirelessly with a care provider.
For more information or to request access to investor's materials, you can visit their website at https://SkylitMedical.com.